https://www.selleckchem.com/pr....oducts/amlexanox.htm
We assessed the prevalence of low bone mineral density (BMD) in oncologic patients undergoing F-FDG PET/CT. This is a retrospective analysis of 100 patients who underwent F-FDG PET/CT at a single center from October 2015 till May 2016. Quantitative CT (QCT) was used to assess BMD at the lumbar spine (BMDQCT) and femoral necks (BMDCTXA). SUVmax was used to evaluate metabolic activity of the bone marrow. Risk of osteoporosis-related fractures was calculated with femoral neck BMDCTXA and the FRAX algorithm, which was compared against mea
Like
Comment
Share
